There was no significant association between a KRAS mutation and CIN in these cancers, with a KRAS mutation present in 43% (32 of 74) CIN cancers, and in 56% (9 of 16) CIN-negative cancers (Table 2). The gene discussed is KRAS; the disease is cancer.